18th Feb 2014 15:38
THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM JAPAN, CANADA OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A BREACH OF THE RELEVANT SECURITIES LAWS OF SUCH JURISDICTION.
TyraTech, Inc.
("TyraTech" or the "Company")
Result of Special Meeting
Further to the announcement dated 31 January 2014, TyraTech, Inc. (AIM: TYR and TYRU), a natural life sciences company, is pleased to announce that at the Special Meeting held earlier today, each of the resolutions as set out in the notice of Special Meeting was duly passed. Accordingly, the Fundraise (as defined in the circular dated 4 February 2014) is now unconditional save for admission.
Accordingly, the Company has approved, subject only to Admission, the issue of 37,391,763 new common shares in the capital of the Company of $0.001 each (the "New Common Shares") at 5 pence per share to the investors participating in the Fundraise.
Application has been made to the London Stock Exchange for the New Common Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission and the commencement of dealings will take place at 8.00 a.m. on 21 February 2014.
Following Admission, the Company will have 206,168,068 common shares of $0.001 each ("Common Shares") in issue, of which 1,084,413 will continue to be held in Treasury. Therefore, the total number of voting rights in the Company will be 205,083,655 ("Total Voting Rights"). The number of restricted Common Shares trading under TIDM 'TYR' following Admission will be 154,744,339 and the number of unrestricted Common Shares trading under TIDM 'TYRU' following Admission will be 51,423,729.
Following Admission, the directors of the Company will hold the following number of Common Shares:
Subscription pursuant to the Fundraise | Total Common Shares held following Admission | Resulting % of Total Voting Rights | |
Alan Reade | 2,000,000 | 12,486,358 | 6.09% |
Bruno Jactel | 494,363 | 1,859,567 | 0.91% |
Barry Riley | 600,000 | 3,055,556 | 1.49% |
James Hills | 482,400 | 1,047,900 | 0.51% |
In addition, the directors are interested in the following options over Common Shares:
Options held over Common Shares in the Company | Option exercise price | Expiry date | |
Alan Reade | 550,000 | £0.105 | 4 February 2020 |
995,125 | £0.12 | 20 October 2020 | |
1,000,000 | £0.06 | 25 April 2022 | |
100,570 | £0.12 | 6 March 2022 | |
Bruno Jactel | 500,000 | £0.06 | 1 January 2023 |
500,000 | £0.12 | 1 January 2023 | |
500,000 | £0.15 | 1 January 2023 | |
Barry Riley | 200,000 | £0.12 | 20 October 2020 |
350,000 | £0.06 | 25 April 2022 | |
James Hills | 200,000 | £0.12 | 20 October 2020 |
350,000 | £0.06 | 25 April 2022 |
Further, at the Special Meeting the issue of up to a further 1,152,700 common shares pursuant to the exercise of warrants to subscribe for common shares granted to Spark Advisory Partners Limited, Allenby Capital Limited and Whitman Howard Limited was also approved.
For further information please contact:
TyraTech Inc.Alan Reade, Non-Executive ChairmanBruno Jactel, Chief Executive Officer | Tel: +44 7841978709Tel: +1 919 415 4340 |
SPARK Advisory Partners Limited, Nominated Adviser Matt Davis / Mark Brady | Tel: +44203 368 3551 Tel: +44203 368 3552 |
Allenby Capital Limited , Joint BrokerChris Crawford | Tel: +44 20 3328 5656 |
Whitman Howard Limited, Joint BrokerRanald Mc-Gregor Smith / Niall Devins | Tel: +44 20 7087 4555 |
Walbrook, Financial PR and IRBob Huxford /Guy McDougall (Public Relations)Paul Cornelius (Investor Relations) | Tel: +44 20 7933 8792Tel: +44 20 7933 8794 |
Related Shares:
TyratechTyratech Com Shares